About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

The Effect of MK0633 in Patients With Chronic Asthma (0633-007)

NCT00404313·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Merck Sharp & Dohme LLC

Age

18–70

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Documented clinical history of symptoms of chronic asthma, including dyspnea, wheezing, chest tightness, cough, and/or sputum production
Males and females 18-70 years of age

You may not be if

History of kidney or chronic liver disease
Recent history of heart problems within the past 3 months
Evidence of another clinically significant, active lung disorder such as bronchiectasis or COPD

The record

StatusTerminated

PhasePhase 2

Taking part688

StartedJan 2008

UpdatedOct 20, 2015

Conditions

Clareo Health | The Effect of MK0633 in Patients With Chronic Asthma (0633-007)